Correlation Between X4 Pharmaceuticals and Relay Therapeutics
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Relay Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Relay Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Relay Therapeutics, you can compare the effects of market volatilities on X4 Pharmaceuticals and Relay Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Relay Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Relay Therapeutics.
Diversification Opportunities for X4 Pharmaceuticals and Relay Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between XFOR and Relay is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Relay Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relay Therapeutics and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Relay Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relay Therapeutics has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Relay Therapeutics go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Relay Therapeutics
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to under-perform the Relay Therapeutics. In addition to that, X4 Pharmaceuticals is 1.33 times more volatile than Relay Therapeutics. It trades about -0.05 of its total potential returns per unit of risk. Relay Therapeutics is currently generating about -0.04 per unit of volatility. If you would invest 683.00 in Relay Therapeutics on August 28, 2024 and sell it today you would lose (197.00) from holding Relay Therapeutics or give up 28.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. Relay Therapeutics
Performance |
| Timeline |
| X4 Pharmaceuticals |
| Relay Therapeutics |
X4 Pharmaceuticals and Relay Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and Relay Therapeutics
The main advantage of trading using opposite X4 Pharmaceuticals and Relay Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Relay Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relay Therapeutics will offset losses from the drop in Relay Therapeutics' long position.| X4 Pharmaceuticals vs. Eliem Therapeutics | X4 Pharmaceuticals vs. Scpharmaceuticals | X4 Pharmaceuticals vs. Milestone Pharmaceuticals | X4 Pharmaceuticals vs. Seres Therapeutics |
| Relay Therapeutics vs. Eliem Therapeutics | Relay Therapeutics vs. Scpharmaceuticals | Relay Therapeutics vs. Milestone Pharmaceuticals | Relay Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |